Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
AZD4831 (Mitiperstat) | Myeloperoxidase inhibitor | Probechem Biochemicals
(PDF) Myeloperoxidase inhibitor AZD4831 target engagement and safety in ...
(PDF) The myeloperoxidase inhibitor mitiperstat ( AZD4831 ) does not ...
(PDF) Biotransformation of the Novel Myeloperoxidase Inhibitor AZD4831 ...
Biotransformation of the Novel Myeloperoxidase Inhibitor AZD4831 in ...
AZD4831 | 1933460-19-5
AZD4831 - CAS:1933460-19-5 - Shanghai Tachizaki Biomedical Research Center
AstraZeneca’s investigational MPO inhibitor AZD4831 shows promise in ...
Total drug-related exposure of AZD4831 and the detected metabolites in ...
Study on the Safety and Effects of AZD4831 for Adults with Non ...
AZD4831 | Dennis Koester
Discovery of AZD4831, a Mechanism-Based Irreversible Inhibitor of ...
Figure 1 from Biotransformation of the Novel Myeloperoxidase Inhibitor ...
(PDF) Discovery of AZD4831, a Mechanism-Based Irreversible Inhibitor of ...
Mitiperstat (AZD4831) | MPO Inhibitors | TargetMol
Application of Accelerator Mass Spectrometry to Characterize the Mass ...
Early Clinical Experience With AZD4831, A Novel Myeloperoxidase ...
Safety, tolerability, pharmacokinetics and effect on serum uric acid of ...
Scheme 2. Synthesis of Compound 16 (AZD4831) a | Download Scientific ...
(PDF) Correction to “Discovery of AZD4831, a Mechanism-Based ...
(PDF) Safety, tolerability, pharmacokinetics and effect on serum uric ...
(PDF) Early Clinical Experience With AZD4831, A Novel Myeloperoxidase ...
The myeloperoxidase inhibitor mitiperstat (AZD4831) does not prolong ...
Journal of Medicinal Chemistry
discovery-of-azd4831-a-mechanism-based-irreversible-inhibitor-of ...
Predicted myeloperoxidase activity and plasma drug concentration versus ...
Mitiperstat (AZD4831) | MPO Inhibitor | MedChemExpress
Spike corrected zymosan stimulated myeloperoxidase (MPO) activity ...
First Disclosures from ACS Chicago 2022
Myeloperoxidase Inhibition Reverses Biomarker Profiles Associated With ...
Myeloperoxidase Inhibition in Heart Failure With Preserved or Mildly ...
Full article: Myeloperoxidase as a therapeutic target for oxidative ...
更新目前各个心衰药物的状态 $信立泰(SZ002294)$ 有球友翻出了 阿斯利康 （AstraZeneca）与Moderna 合作开发的 ...
Scheme 2. Synthesis of Compound 16 (AZD4831) a | Download High-Quality ...
Early clinical drug product shelf-life setting using accelerated ...
An Efficacy and Safety Study of Mitiperstat (AZD4831) (MPO inhibitor ...
The Roles of Neutrophil-Derived Myeloperoxidase (MPO) in Diseases: The ...
Mitiperstat|CAS 1933460-19-5|DC Chemicals
Dose-dependent inhibition of peritoneal myeloperoxidase by compound 16 ...
Role of Myeloperoxidase, Oxidative Stress, and Inflammation in ...
Whole-body autoradiography 24 h after an oral dose of [ 14 C]-16 ...
Geometric mean + SD* trough concentration‐time profiles by treatment ...
Heart Failure Drugs in the Pipeline: Six Novel Therapeutics to Note
LEXICON’s INPEFA for Heart Failure Treatment | Key Analysis
髓过氧化物酶抑制剂米替普司他 (AZD4831) 在预期治疗剂量下不会延长 QT 间期,Pharmacology Research ...
Role of Dapagliflozin in patients with CKD in ESC 2023 | PPTX
AstraZeneca MPO inhibitor shows promise for heart failure patients ...
Geometric mean + SD* of spike corrected zymosan stimulated ...
Schematic of AZD0466 drug substance and drug product process. A ...
Lipinski rules for the proposed derivatives. | Download Scientific Diagram
Rafid Taj Aldeen on LinkedIn: Discovery of AZD4831, a Mechanism-Based ...
Tal Varsano on LinkedIn: Myeloperoxidase Inhibition Reverses Biomarker ...
Study flow chart according to CONSORT 2010 guidelines. The design of a ...
AZ drug for hard-to-treat heart failure has mixed results in trial ...
Structure of AZD3582. | Download Scientific Diagram
Proteases(蛋白酶)
The effect of severe renal impairment on the pharmacokinetics, safety ...
Astegolimab SC Q2W for Chronic Obstructive Pulmonary Disease Clinical ...
Hans ERICSSON | AstraZeneca, London | AZ | Drug Metabolism ...
Geometric mean + SD* for plasma concentration‐time profiles by ...
Mitiperstat | Glutathione Peroxidase | TargetMol
Ensifentrine for Chronic Obstructive Pulmonary Disease (COPD) Clinical ...
AZD-4818 |CAS:1003566-93-5 Probechem Biochemicals
Gallium Ga 68 Gozetotide for Hepatocellular Carcinoma Clinical Trial ...
AZD3965 | MCT1 Inhibitor | MedChemExpress
Patient Disposition and Baseline Characteristics | Download Scientific ...
:%0A%0AAstegolimab%20SC%20Q2W%20for%20Chronic%20Obstructive%20Pulmonary%20Disease.png?md=1)
:%0A%0AEnsifentrine%20for%20Chronic%20Obstructive%20Pulmonary%20Disease%20(COPD).png?md=1)
